<SEC-DOCUMENT>0001104659-25-072805.txt : 20250801
<SEC-HEADER>0001104659-25-072805.hdr.sgml : 20250801
<ACCEPTANCE-DATETIME>20250731184611
ACCESSION NUMBER:		0001104659-25-072805
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20250731
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250801
DATE AS OF CHANGE:		20250731

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Cytosorbents Corp
		CENTRAL INDEX KEY:			0001175151
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		EIN:				980373793
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36792
		FILM NUMBER:		251173222

	BUSINESS ADDRESS:	
		STREET 1:		305 COLLEGE ROAD EAST
		CITY:			PRINCETON
		STATE:			NJ
		ZIP:			08540
		BUSINESS PHONE:		973-329-8885

	MAIL ADDRESS:	
		STREET 1:		305 COLLEGE ROAD EAST
		CITY:			PRINCETON
		STATE:			NJ
		ZIP:			08540

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MedaSorb Technologies CORP
		DATE OF NAME CHANGE:	20060807

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	GILDER ENTERPRISES INC
		DATE OF NAME CHANGE:	20020611
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>tm2522255d1_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:us-roles="http://fasb.org/us-roles/2025" xmlns:country="http://xbrl.sec.gov/country/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:ctso="http://cytosorbents.com/20250731">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02E_US%2DGAAP%2D2025 -->
<!-- Field: Set; Name: xdx; ID: xdx_03E_ctso_cytosorbents.com_20250731 -->
<!-- Field: Set; Name: xdx; ID: xdx_04A_20250731_20250731 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_054_edei%2D%2DEntityCentralIndexKey_0001175151 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2025-07-31" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-07-31" id="Fact000004" name="dei:EntityCentralIndexKey">0001175151</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="ctso-20250731.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2025-07-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001175151</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-07-31</xbrli:startDate>
        <xbrli:endDate>2025-07-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<!-- Field: Rule-Page --><div style="margin-top: 12pt; margin-bottom: 3pt; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin: 0">&#160;</p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES </b></p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Washington D.C. 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM <span id="xdx_904_edei--DocumentType_c20250731__20250731_zMLzpk1IMvsi"><ix:nonNumeric contextRef="AsOf2025-07-31" id="Fact000009" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CURRENT REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="text-transform: uppercase">Pursuant
to Section 13 or 15(</span>d<span style="text-transform: uppercase">)<br/>
of the Securities Exchange Act of 1934</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Date of Report (Date of Earliest Event Reported):
<b><span id="xdx_906_edei--DocumentPeriodEndDate_c20250731__20250731_zvknEXRafsi7"><ix:nonNumeric contextRef="AsOf2025-07-31" format="ixt:datemonthdayyearen" id="Fact000010" name="dei:DocumentPeriodEndDate">July 31, 2025</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_90D_edei--EntityRegistrantName_c20250731__20250731_zUoplx6d4Sve"><ix:nonNumeric contextRef="AsOf2025-07-31" id="Fact000011" name="dei:EntityRegistrantName">CYTOSORBENTS CORPORATION</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact name of registrant as specified in
its charter)&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="vertical-align: top; text-align: center; width: 32%"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_905_edei--EntityIncorporationStateCountryCode_c20250731__20250731_ztjPgSvwJHK1"><ix:nonNumeric contextRef="AsOf2025-07-31" format="ixt-sec:stateprovnameen" id="Fact000012" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>
    <td style="vertical-align: bottom; width: 2%">&#160;</td>
    <td style="vertical-align: top; text-align: center; width: 32%"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_907_edei--EntityFileNumber_c20250731__20250731_zrrSgMMSWb2a"><ix:nonNumeric contextRef="AsOf2025-07-31" id="Fact000013" name="dei:EntityFileNumber">001-36792</ix:nonNumeric></span></b></span></td>
    <td style="vertical-align: bottom; width: 2%">&#160;</td>
    <td style="vertical-align: top; text-align: center; width: 32%"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_905_edei--EntityTaxIdentificationNumber_c20250731__20250731_zrNxzdIGhfy5"><ix:nonNumeric contextRef="AsOf2025-07-31" id="Fact000014" name="dei:EntityTaxIdentificationNumber">98-0373793</ix:nonNumeric></span></b></span></td></tr>
<tr>
    <td style="vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(State or other jurisdiction of<br/>
incorporation)</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(Commission File Number)</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(I.R.S. Employer Identification No.)</span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="vertical-align: top; width: 50%">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_90C_edei--EntityAddressAddressLine1_c20250731__20250731_zsLKKsVHkm48"><b><ix:nonNumeric contextRef="AsOf2025-07-31" id="Fact000015" name="dei:EntityAddressAddressLine1">305
        College Road East</ix:nonNumeric></b></span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_905_edei--EntityAddressCityOrTown_c20250731__20250731_zVxTtT6G9zdl"><ix:nonNumeric contextRef="AsOf2025-07-31" id="Fact000016" name="dei:EntityAddressCityOrTown">Princeton</ix:nonNumeric></span>, <span id="xdx_902_edei--EntityAddressStateOrProvince_c20250731__20250731_zlB8lvRQRac5"><ix:nonNumeric contextRef="AsOf2025-07-31" format="ixt-sec:stateprovnameen" id="Fact000017" name="dei:EntityAddressStateOrProvince">New Jersey</ix:nonNumeric></span></b></p></td>
    <td style="vertical-align: bottom; text-align: center; font-size: 10pt; width: 50%"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_902_edei--EntityAddressPostalZipCode_c20250731__20250731_zapsMbjwmDN4"><ix:nonNumeric contextRef="AsOf2025-07-31" id="Fact000018" name="dei:EntityAddressPostalZipCode">08540</ix:nonNumeric></span></b></span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: center; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">(Address of principal executive offices)</span></td>
    <td style="text-align: center; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">(Zip Code)</span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Registrant&#8217;s telephone number, including
area code: <b>(<span id="xdx_902_edei--CityAreaCode_c20250731__20250731_zqIoZDlG31Kh"><ix:nonNumeric contextRef="AsOf2025-07-31" id="Fact000019" name="dei:CityAreaCode">732</ix:nonNumeric></span>) <span id="xdx_90E_edei--LocalPhoneNumber_c20250731__20250731_zbNncY4gb8a5"><ix:nonNumeric contextRef="AsOf2025-07-31" id="Fact000020" name="dei:LocalPhoneNumber">329-8885</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="width: 100%; font-size: 10pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Not Applicable</b></p>
</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt; text-align: center">(Former name or former address, if changed since last report.)</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction
A.2. below):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
<tr style="vertical-align: top; text-align: justify">
    <td style="width: 0in">&#160;</td>
    <td style="width: 0.25in; text-align: left"><span style="font-family: Wingdings"><span id="xdx_900_edei--WrittenCommunications_c20250731__20250731_zjGL2eo6Vn5i"><ix:nonNumeric contextRef="AsOf2025-07-31" format="ixt:booleanfalse" id="Fact000021" name="dei:WrittenCommunications">&#168;</ix:nonNumeric></span></span>&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
<tr style="vertical-align: top; text-align: justify">
    <td style="width: 0in">&#160;</td>
    <td style="width: 0.25in; text-align: left"><span style="font-family: Wingdings"><span id="xdx_900_edei--SolicitingMaterial_c20250731__20250731_zFdNaw91zHTc"><ix:nonNumeric contextRef="AsOf2025-07-31" format="ixt:booleanfalse" id="Fact000022" name="dei:SolicitingMaterial">&#168;</ix:nonNumeric></span></span>&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
<tr style="vertical-align: top; text-align: justify">
    <td style="width: 0in">&#160;</td>
    <td style="width: 0.25in; text-align: left"><span style="font-family: Wingdings"><span id="xdx_902_edei--PreCommencementTenderOffer_c20250731__20250731_z3umWTSdlLUk"><ix:nonNumeric contextRef="AsOf2025-07-31" format="ixt:booleanfalse" id="Fact000023" name="dei:PreCommencementTenderOffer">&#168;</ix:nonNumeric></span></span>&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
<tr style="vertical-align: top; text-align: justify">
    <td style="width: 0in">&#160;</td>
    <td style="width: 0.25in; text-align: left"><span style="font-family: Wingdings"><span id="xdx_900_edei--PreCommencementIssuerTenderOffer_c20250731__20250731_zeRTQD3ON2Qc"><ix:nonNumeric contextRef="AsOf2025-07-31" format="ixt:booleanfalse" id="Fact000024" name="dei:PreCommencementIssuerTenderOffer">&#168;</ix:nonNumeric></span></span>&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Securities registered pursuant to Section
12(b) of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="border: black 1pt solid; width: 33%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">Title of each class</span></td>
    <td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; width: 28%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">Trading Symbol(s)</span></td>
    <td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; width: 39%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">Name of each exchange on which <br/>
registered</span></td></tr>
<tr style="vertical-align: top">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; text-align: center"><span id="xdx_908_edei--Security12bTitle_c20250731__20250731_z9VQxXLvGXA1" style="font-size: 10pt"><ix:nonNumeric contextRef="AsOf2025-07-31" id="Fact000025" name="dei:Security12bTitle">Common Stock, $0.001 par value</ix:nonNumeric></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; text-align: center"><span style="font-size: 10pt"><span id="xdx_907_edei--TradingSymbol_c20250731__20250731_zIXkFcc4wd9h"><ix:nonNumeric contextRef="AsOf2025-07-31" id="Fact000026" name="dei:TradingSymbol">CTSO</ix:nonNumeric></span></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; text-align: center"><span style="font-size: 10pt">The <span id="xdx_903_edei--SecurityExchangeName_c20250731__20250731_zTogm6IPver7"><ix:nonNumeric contextRef="AsOf2025-07-31" format="ixt-sec:exchnameen" id="Fact000027" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Stock Market LLC (Nasdaq Capital Market)</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Emerging Growth Company <span style="font-family: Wingdings"><span style="font-family: Wingdings"><span id="xdx_904_edei--EntityEmergingGrowthCompany_c20250731__20250731_zfr4tYvOstw1"><ix:nonNumeric contextRef="AsOf2025-07-31" format="ixt:booleanfalse" id="Fact000028" name="dei:EntityEmergingGrowthCompany">&#168;</ix:nonNumeric></span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act. <span style="font-family: Wingdings">&#168;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<!-- Field: Rule-Page --><div style="margin-top: 3pt; margin-bottom: 12pt; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>
<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="white-space: nowrap; vertical-align: top; font-size: 10pt; width: 1in"><b>Item 8.01</b></td>
    <td style="font-size: 10pt"><b>Results of Operation and Financial Condition</b></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On July 31, 2025, CytoSorbents
Corporation (the &#8220;Company&#8221;) issued a press release highlighting the broad mechanisms of action and results of new studies
that demonstrate the vital and evolving role of CytoSorb&#174; therapy in the treatment of sepsis and septic shock. On September 10, 2025,
the Company plans to host a World Sepsis Day Global Webinar in commemoration of Sepsis Awareness Month and World Sepsis Day in September.
A copy of the press release is furnished herewith as Exhibit 99.1.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="white-space: nowrap; vertical-align: top; width: 1in; font-size: 10pt"><b>Item 9.01</b></td>
    <td style="font-size: 10pt"><b>Exhibits</b></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(d) Exhibits</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.5in"><b><span style="text-decoration: underline">Exhibit<br/>
No.</span></b></td>
    <td><b><span style="text-decoration: underline">Description</span></b></td></tr>
  <tr style="vertical-align: top">
    <td><a href="tm2522255d1_ex99-1.htm" style="-sec-extract: exhibit">99.1</a></td>
    <td><a href="tm2522255d1_ex99-1.htm" style="-sec-extract: exhibit">Press Release of the Company, dated July 31, 2025</a></td></tr>
  <tr style="vertical-align: top">
    <td>104</td>
    <td>Cover Page Interactive Data File (embedded with the Inline XBRL document)</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span style="text-decoration: underline">SIGNATURES</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td>Dated: July 31, 2025</td>
    <td colspan="2">CYTOSORBENTS CORPORATION</td></tr>
  <tr style="vertical-align: top">
    <td style="width: 50%">&#160;</td>
    <td style="width: 5%">&#160;</td>
    <td style="width: 45%">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify">By:</td>
    <td style="border-bottom: black 1pt solid; text-align: justify">/s/ Dr. Phillip P. Chan</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>Name:</td>
    <td>Dr. Phillip P. Chan</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>Title:</td>
    <td>Chief Executive Officer</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjU0KwjAQhU/QOwxZi6axLuzSokWsIkXEbbBTCbaZMol/R/KWxhZxGBiG9773hBiJnFamQYbToizggG3XaI9QYo2M9ozBka03KYRb4sU4z9r6/v2BGQUGAzMbK6WD0FvvxmGVgkwmUk1UAnKaxnPYb0X01TOytanQeqMb0LaCPVPHBr3m15Bw0E+y1L76qiOyM2RTiMdykN+gZKxgR3f9IL46KIpMRKN+IpEz3brgWj492i8JywbbUOcG+r/RBwV6Sos= -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>tm2522255d1_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"><B>Exhibit 99.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="image_001.jpg" ALT="" STYLE="height: 117px; width: 623px">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CytoSorbents Leads a New Era in Sepsis Treatment</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><I>CytoSorbents highlights the vital and evolving
role of CytoSorb&reg; in the treatment of sepsis and septic shock ahead of its World Sepsis Day Global Webinar on September 10<SUP>th</SUP></I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">PRINCETON, N.J., July 31, 2025 &mdash;&nbsp;<FONT>CytoSorbents
Corporation</FONT> (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery
using blood purification, highlights new studies that demonstrate the vital and evolving role of CytoSorb&reg; therapy in the treatment
of sepsis and septic shock &ndash; among the deadliest challenges in critical care medicine. Recent data demonstrate early and intensive
use of CytoSorb therapy improves clinical outcomes for patients suffering from these conditions. Today, the Company provides an overview
of CytoSorb&rsquo;s unique approach and the evolving data supporting its use, in advance of its September 10, 2025 World Sepsis Day Global
Webinar &ndash; being held in commemoration of Sepsis Awareness Month and World Sepsis Day in September. Dr. Phillip Chan, MD, PhD, Chief
Executive Officer, will host a special presentation with physician-user guests to discuss CytoSorb therapy best practices and its impact
in the fight against sepsis.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dr. Chan explains, &ldquo;For more than a decade,
CytoSorbents has partnered with clinicians and scientists to improve the treatment of sepsis and septic shock by supplementing traditional
antibiotic therapy with the powerful, broad-spectrum blood purification capability of CytoSorb. While antibiotics target the source of
infection, CytoSorb addresses the other major drivers of septic shock, including severe inflammation, shock, capillary leak, fluid overload,
and organ failure. Recent studies reinforce that, like antibiotics, CytoSorb therapy is most effective when initiated early, applied intensively,
and continued for an appropriate duration. Backed by a strong safety record and many peer-reviewed publications, CytoSorbents and collaborators
are helping to solve this critical problem that claims millions of lives around the world annually.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Sepsis and Septic Shock: A Life-Threatening
Crisis Driven by Inflammation</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Sepsis is a complex, life-threatening condition
where the inflammatory response to a serious infection can spiral out of control, fueled by the excessive production of cytokines (cytokine
storm), bacterial toxins, and other inflammatory agents. Left unchecked, this inflammation can lead to septic shock &ndash; an often
fatal complication marked by circulatory collapse and a lethal drop in blood pressure, the failure of multiple vital organs, and fluid
overload &ndash; essentially drowning the patient from within. Each year, sepsis and septic shock afflict an estimated 49 million people
worldwide, killing 11 million, accounting for up to 20% of all global deaths.&nbsp;</P>

<P STYLE="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Despite decades of effort, standard treatments
of septic shock such as antibiotics, fluids, vasopressors, and organ support are often not enough, with mortality rates of 30-50% that
can escalate rapidly with multiple organ failure. Survivors often face long-term disability and shorter life spans. The complexity of
sepsis has led to the failure of hundreds of therapy candidates and over 100 Phase II and III clinical trials over many decades &ndash;
underscoring the urgent need for more effective solutions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>CytoSorb: A Broad-Spectrum Solution with
Real-World Impact</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">CytoSorb&reg; is a first-in-class, extracorporeal
blood purification therapy approved in the European Union with nearly 300,000 human treatments across more than 70 countries globally.
It uses advanced porous polymer beads to remove a wide array of toxic substances directly from the bloodstream, including, for example,
inflammatory cytokines and mediators, bacterial toxins, and other damaging molecules that contribute to inflammation, shock, blood vessel
damage, and organ injury.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">However, what sets CytoSorb apart from other approaches,
that often simply focus on a single target or pathway, is a comprehensive, multi-faceted approach to the core problems of sepsis and septic
shock. Based on a substantial body of published, peer-reviewed literature, CytoSorb can:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 20.15pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Control inflammation by reducing cytokine storm</FONT>
and a <FONT STYLE="font-family: Times New Roman, Times, Serif">wide array of other inflammatory mediators such as activated complement
</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 20.15pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Remove circulating bacterial toxins</FONT> produced
by the active infection that can cause widespread inflammation and tissue damage</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 20.15pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Redirect activated immune cells to sites of infection</FONT>
and away from healthy tissues thereby reducing collateral damage</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 20.15pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Reverse shock and restore natural blood pressure</FONT>,
reducing the need for vasopressors and restoring oxygenated blood flow to vital organs</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 20.15pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Improve microcirculation</FONT> among small blood
vessels, <FONT STYLE="font-family: Times New Roman, Times, Serif">improving oxygen delivery to tissues and organs like the kidney</FONT>
and <FONT STYLE="font-family: Times New Roman, Times, Serif">reducing lactic acidosis</FONT> &ndash; an independent risk factor of mortality</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 20.15pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Protect blood vessels and promote reversal of
leaky blood vessels (capillary leak)</FONT> by <FONT STYLE="font-family: Times New Roman, Times, Serif">binding and removing numerous
toxic substances in the blood that damage or kill the endothelial cells lining the blood vessel wall</FONT></TD></TR></TABLE>


 <P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->



<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 20.15pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Remove excessive fluid and improve fluid balance</FONT>
once capillary leak is resolved</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 20.15pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Improve lung function and reduce time on mechanical
support</FONT> such as mechanical ventilation and extracorporeal membrane oxygenation (ECMO)</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 20.15pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prevent and treat sepsis-associated
acute kidney injury</FONT><FONT STYLE="font-size: 10pt"><B>, </B>key to maintaining the ability to remove excessive fluid, maintain proper
acid base balance, and eliminate toxic metabolic wastes</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 20.15pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Remove liver toxins and support
liver dysfunction</FONT> <FONT STYLE="font-size: 10pt">that is common in sepsis</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This broad-spectrum approach helps to support
five essential treatment goals of CytoSorb in septic shock:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><B>1)</B></TD><TD STYLE="text-align: justify"><B>Break the vicious cycle of uncontrolled inflammation</B></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">2)</TD><TD STYLE="text-align: justify"><B>Reverse shock and restore oxygenated blood flow </B></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">3)</TD><TD STYLE="text-align: justify"><B>Promote the repair of leaky blood vessels </B></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">4)</TD><TD STYLE="text-align: justify"><B>Actively remove excessive fluid and reduce fluid overload in organs</B></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">5)</TD><TD STYLE="text-align: justify"><B>Prevent or treat multiple organ failure</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Like antibiotics, CytoSorb works best when used
early, intensively, and at the right dose &ndash; the foundation of the Company&rsquo;s &ldquo;Right patient, Right Timing, Right Dosing&rdquo;
educational campaign.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Positive Clinical Results Backing Early
and Intensive CytoSorb Use</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">CytoSorbents' clinical
impact is supported by <FONT STYLE="font-family: Times New Roman, Times, Serif">hundreds of peer-reviewed publications <B>in many different
clinical applications such as sepsis</B></FONT>, including data from the COVID-19 pandemic, where CytoSorb was granted U.S. <FONT STYLE="font-family: Times New Roman, Times, Serif"><B>FDA
Emergency Use Authorization </B></FONT>in critically ill COVID-19 patients with respiratory failure. In the <FONT STYLE="font-family: Times New Roman, Times, Serif">100-patient,
multi-center registry of U.S. COVID-19 patients on CytoSorb and ECMO, published in the journal Critical Care</FONT></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif">(2023)</FONT>,
<FONT STYLE="font-size: 10pt">where all had refractory respiratory failure and sepsis with 76% in septic shock, Hayanga and colleagues
reported 74% <FONT STYLE="font-family: Times New Roman, Times, Serif"><B>90-day survival,</B></FONT> that rose to <FONT STYLE="font-family: Times New Roman, Times, Serif"><B>82%
in those treated early. This </B></FONT>significantly outperformed published <FONT STYLE="font-family: Times New Roman, Times, Serif">U.S.
survival benchmarks</FONT> of approximately 50% when CytoSorb was not used.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">A separate, <FONT STYLE="font-family: Times New Roman, Times, Serif">retrospective
study of 175 septic shock patients recently published by Berlot and team in the Journal of Intensive Care Medicine</FONT></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif">(2025)</FONT>
<FONT STYLE="font-size: 10pt">demonstrated that <FONT STYLE="font-family: Times New Roman, Times, Serif"><B>early and intensive CytoSorb
use</B></FONT> (&ge;3 cartridges within 2&ndash;3 days) nearly <FONT STYLE="font-family: Times New Roman, Times, Serif"><B>doubled survival
rates</B></FONT> (70% observed vs. 37% predicted), with strong correlations between clinical benefit and treatment intensity. The study
also corroborated the findings of another 75 septic shock patient retrospective study published by Schultz, et al. (2021) in the <FONT STYLE="font-family: Times New Roman, Times, Serif">Journal
of Critical Care</FONT> that correlated survival with higher volumes of blood treated, highlighting that duration of treatment is critically
important.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Further strengthening the evidence base, the <FONT STYLE="font-family: Times New Roman, Times, Serif">first
meta-analysis of 744 patients with septic shock</FONT> by Steindl and colleagues from Charit&eacute; Berlin Hospital was recently reported
in the <FONT STYLE="font-family: Times New Roman, Times, Serif">Journal of Clinical Medicine (2025)</FONT> comparing 449 patients treated
with CytoSorb and standard of care versus 295 control patients receiving standard of care alone. The study demonstrated statistically
significant improvements in hemodynamics, vasopressor requirements, and survival compared to control patients, where CytoSorb:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Reduced in-hospital mortality</B></FONT> (OR
0.64 [0.42&ndash;0.97], p=0.036, n=462)</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Halved 28&ndash;30 day mortality</B></FONT>
(OR 0.46 [0.28&ndash;0.78], p=0.003, n=250)</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Meanwhile, results from the <FONT STYLE="font-family: Times New Roman, Times, Serif">first
150 patients enrolled into the international, prospective COSMOS (CytOSorb treatMent Of critically ill patientS) critical care registry
by Ferrer and collaborators was recently published in the Journal of Intensive Medicine (2025)</FONT>, where 58% of patients had septic
shock, highlighting improved mortality compared with risk-based predictions and significant improvements in oxygenation, shock reversal,
fluid balance, and lactate levels before and after use of CytoSorb.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Overall, these results highlight CytoSorb&rsquo;s
ability to intervene across the pathophysiology of septic shock, setting it apart from previous drug and device-based approaches that
failed to show consistent benefit.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dr. Chan concluded, &ldquo;Septic shock remains
one of the most devastating and complex challenges in critical care. Despite decades of research, outcomes remain poor with limited treatment
options. CytoSorb, guided by the experience and insight of clinicians and scientists around the world, is helping that change that. With
an ever-expanding body of published clinical evidence - including hundreds of peer-reviewed studies such as those mentioned above, real-world
data, and impactful success stories, CytoSorb continues to evolve as a powerful therapy to treat critical illnesses such as septic shock,
particularly when used early, intensively, and of the right duration &ndash; just like antibiotics. In treating the sickest patients in
the hospital, we are proud of our mission of working to save lives&hellip;together.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For more detailed information, follow our new
septic shock blog series where CytoSorbents delves into greater detail on these points, found <FONT STYLE="font-family: Times New Roman, Times, Serif"><U>here</U></FONT>.
Meanwhile, watch videos from healthcare providers from around the world who detail their first-hand experiences with CytoSorb in the
treatment of septic shock and other critical illnesses in our &ldquo;Voices Around the World&rdquo; segment, found <FONT STYLE="font-family: Times New Roman, Times, Serif"><U>here</U></FONT>.
Please join us for our World Sepsis Day Global Webinar on September 10, 2025 (details to come), where we will explore best practices
in the treatment of septic shock with CytoSorb with some of the pioneering clinicians who are fighting this battle daily on the front
lines.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>About CytoSorbents Corporation (NASDAQ: CTSO)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #464444">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">CytoSorbents
Corporation</FONT> is a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery through
blood purification. CytoSorbents&rsquo; proprietary blood purification technologies are based on biocompatible, highly porous polymer
beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. Cartridges
filled with these beads can be used with standard blood pumps already in the hospital (e.g. dialysis, continuous renal replacement therapy
or CRRT, extracorporeal membrane oxygenation or ECMO, and heart-lung machines), where blood is repeatedly recirculated outside the body,
through our cartridges where toxic substances are removed, and then back into the body. CytoSorbents&rsquo; technologies are used in a
number of broad applications. Specifically, two important applications are 1) the removal of blood thinners during and after cardiothoracic
surgery to reduce the risk of severe bleeding, and 2) the removal of inflammatory agents and toxins in common critical illnesses that
can lead to massive inflammation, organ failure and patient death. The breadth of these critical illnesses includes, for example, sepsis,
burn injury, trauma, lung injury, liver failure, cytokine release syndrome, and pancreatitis as well as the removal of liver toxins that
accumulate in acute liver dysfunction or failure, and the removal of myoglobin in severe rhabdomyolysis that can otherwise lead to renal
failure. In these diseases, the risk of death can be extremely high, and there are few, if any, effective treatments.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">CytoSorbents&rsquo; lead product, CytoSorb&reg;,
is approved in the European Union and distributed in over 70 countries worldwide, with nearly 300,000 devices used cumulatively to date.
CytoSorb was originally launched in the European Union under CE mark as the first cytokine adsorber. Additional CE mark extensions were
granted for bilirubin and myoglobin removal in clinical conditions such as liver disease and trauma, respectively, and for ticagrelor
and rivaroxaban removal in cardiothoracic surgery procedures. CytoSorb has also received FDA Emergency Use Authorization in the United
States for use in adult critically ill COVID-19 patients with impending or confirmed respiratory failure. CytoSorb is not yet approved
or cleared in the United States.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the&nbsp;U.S.&nbsp;and&nbsp;Canada,&nbsp;CytoSorbents&nbsp;is
developing the DrugSorb&trade;-ATR antithrombotic removal system, an investigational device based on an equivalent polymer technology
to CytoSorb, to reduce the severity of perioperative bleeding in high-risk surgery due to blood thinning drugs.&nbsp; It has received
two&nbsp;FDA Breakthrough Device Designations:&nbsp; one for the removal of&nbsp;ticagrelor&nbsp;and another for the removal of the&nbsp;direct
oral anticoagulants (DOAC) apixaban and rivaroxaban&nbsp;in a cardiopulmonary bypass circuit during urgent cardiothoracic procedures.&nbsp;
In&nbsp;September 2024, the Company&nbsp;submitted a De Novo Request to the&nbsp;U.S.&nbsp;FDA&nbsp;requesting marketing authorization
for the DrugSorb-ATR medical device to reduce the severity of perioperative bleeding in CABG patients on the antithrombotic drug ticagrelor,
which was&nbsp;accepted for substantive review in&nbsp;October 2024.&nbsp; On&nbsp;April 25, 2025, the FDA issued a De&nbsp;Novo Denial
Letter&nbsp;for DrugSorb-ATR, identifying remaining deficiencies that must be addressed before the De Novo Request can be granted and
the device authorized for&nbsp;U.S.&nbsp;commercialization.&nbsp; The Company believes these items can be most effectively and expeditiously
resolved through the formal appeals process, which facilitates engagement with FDA senior leadership and our external surgical experts.&nbsp;On
June 27, 2025, the FDA confirmed the scheduling of an appeal hearing date for the Company&rsquo;s request for supervisory review (administrative
appeal) under 21 CFR 10.75. The Company continues to believe that remaining deficiencies in its De Novo application can be effectively
resolved through this supervisory review process which is expected to be completed by the end of August 2025, and that a final regulatory
decision can be achieved in 2025.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In&nbsp;November 2024, the Company received its
<FONT STYLE="font-family: Times New Roman, Times, Serif">MDSAP&nbsp;certification and submitted its Medical Device License (MDL) application
to&nbsp;Health Canada</FONT>.&nbsp; On June 26, 2025, Health Canada issued a Notice of Refusal of the Company&rsquo;s Medical Device License
application, identifying remaining deficiencies that must be addressed before the application may be granted and the device authorized
for commercialization. As part of Health Canada&rsquo;s prescribed reconsideration process, and after discussions with Health Canada,
the Company plans to file a Level 1 &ldquo;Request for Reconsideration&rdquo; with the Medical Devices Directorate Bureau Director following
completion of the Company&rsquo;s review with the U.S. FDA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">DrugSorb-ATR has not been authorized for commercialization
in the&nbsp;U.S.&nbsp;or Canada.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has numerous marketed products and
products under development based upon this unique blood purification technology protected by many issued&nbsp;U.S.&nbsp;and international
patents and registered trademarks, and multiple patent applications pending, including ECOS-300CY&reg;, VetResQ&reg;, PuriFi&reg;, CytoSorb-XL&trade;,
HemoDefend-RBC&trade;, HemoDefend-BGA&trade;, K+ontrol&trade;, DrugSorb&trade;, ContrastSorb, and others. For more information, please
visit the Company&rsquo;s website at&nbsp;<U>https://ir.cytosorbents.com/</U>&nbsp;&nbsp;or follow us on&nbsp;<U>Facebook</U>&nbsp;and&nbsp;<U>X</U>.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #403F42">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #403F42"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #403F42">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Forward-Looking Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white">This press
release includes forward-looking statements intended to qualify for the safe harbor from liability established by the Private Securities
Litigation Reform Act of 1995. These forward-looking statements include, but are not limited to, statements about our plans, objectives,
future targets and outlooks for our business, representations and contentions, and the outcome of our regulatory submissions, and are
not historical facts and typically are identified by use of terms such as &ldquo;may,&rdquo; &ldquo;should,&rdquo; &ldquo;could,&rdquo;
 &ldquo;expect,&rdquo; &ldquo;plan,&rdquo; &ldquo;anticipate,&rdquo; &ldquo;believe,&rdquo; &ldquo;estimate,&rdquo; &ldquo;predict,&rdquo;
 &ldquo;potential,&rdquo; &ldquo;continue&rdquo; and similar words, although some forward-looking statements are expressed differently.
You should be aware that the forward-looking statements in this press release represent management&rsquo;s current judgment and expectations,
but our actual results, events and performance could differ materially from those in the forward-looking statements. Factors which could
cause or contribute to such differences include, but are not limited to, our restructuring of our direct sales team and strategy in Germany,
our ability to resolve remaining deficiencies in the FDA denial letter and the Health Canada Notice of Refusal and/or successfully appeal
the FDA&rsquo;s and Health Canada&rsquo;s decision, and the risks discussed in our Annual Report on Form 10-K, filed with the SEC on March
31, 2025, as updated by the risks reported in our Quarterly Reports on Form 10-Q, and in the press releases and other communications to
shareholders issued by us from time to time which attempt to advise interested parties of the risks and factors which may affect our business.
We caution you not to place undue reliance upon any such forward-looking statements. We undertake no obligation to publicly update or
revise any forward-looking statements, whether as a result of new information, future events, or otherwise, other than as required under
the Federal securities laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>Please Click to Follow Us on Facebook and
X</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>U.S. Company
Contact:</B></FONT><B><BR>
</B>Peter J. Mariani, Chief Financial Officer</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">305 College Road East</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Princeton, NJ 08540</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>pmariani@cytosorbents.com</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Investor Relations Contact:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Aman Patel, CFA &amp; Adanna G. Alexander, PhD</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>ICR Healthcare </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>ir@cytosorbents.com</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>ctso-20250731.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.1a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +aA5w7xRiXgen8uLa3ZcWaGHGbOdzZR+yYkxtmB/bekKzyEpquM/hicEN4amMfkD -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:srt-types="http://fasb.org/srt-types/2025" xmlns:ctso="http://cytosorbents.com/20250731" elementFormDefault="qualified" targetNamespace="http://cytosorbents.com/20250731">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://cytosorbents.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="ctso-20250731_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="ctso-20250731_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" />
    <import namespace="http://fasb.org/us-gaap/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd" />
    <import namespace="http://fasb.org/us-types/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2025" schemaLocation="https://xbrl.sec.gov/country/2025/country-2025.xsd" />
    <import namespace="http://fasb.org/srt/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd" />
    <import namespace="http://fasb.org/srt-types/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>ctso-20250731_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.1a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>ctso-20250731_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.1a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="ctso-20250731.xsd#Cover" roleURI="http://cytosorbents.com/role/Cover" />
    <link:presentationLink xlink:type="extended" xlink:role="http://cytosorbents.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $,!98# 2(  A$! Q$!_\0
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M !1110 4444 %%>%_&?_ )'"T_Z\$_\ 1DE>=5V0PW-%2N!]<T5\C5K^%/\
MD<-$_P"O^#_T8M4\)97N!]14445P@%%%% !1110 4444 %%%% !7FWBGXC21
M7#V6A/'M3A[L@-DY_@!XQVR<YSQV)U?B3K#Z?H4=C"662^8JS#/$:XW#(/?*
MCW!->05Z.$PZDN>1QXBLT^6)+<W5Q>3&:ZGEGE/!>5RS'\345%%>H< 4444
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M*-CURBBBN ZPHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MAA.=<T]CGJXCE?+'<]"O?BK=-Q8:;#'AC\T[E\CMP,8/XFJ?_"TM;_Y]=/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M.&Q[9!Q[5\_5[#\,KB2?PHT;D%8+EXT]AA6_FQKAQT;P4NQUX65I6,CXL_\
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MS<_]?C?^@)7;UX&(5JLO4]:C_#04445B:A1110 4444 %%%% !1110 4444
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M&^XC DM8V'ORP_I7 U[%'^&@"M?PI_R.&B?]?\'_ *,6LBM?PI_R.&B?]?\
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M_P#>)?/\SMK?P8_(YJBBBO2.(Z7P!_R.VG?]M/\ T6U>D^/_ /D2=1_[9_\
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M&EV,X.TDV?0%?/WB+_D9M5_Z_)O_ $,U[%>>--!M-.^UKJ,$VY<I%&V78XR
M5'*^G(&.]>'W$\MU<RW$S;Y97+NV,98G)/YUP8*$DVVCJQ4DTDB.BBBO2.(]
M*^$W_,7_ .V/_L]'Q9_YA'_;;_V2I?A1;2+9ZG=$#RI)(XU.><J"3_Z&*D^*
MMH'TO3[S?@Q3-%MQUWKG/X;/UKS+KZW_ %V.ZW^S_P!=SRRBBBO3.$TO#O\
MR,VD_P#7Y#_Z&*]O\1?\BSJW_7G-_P"@&O!K"Z-CJ-K=J,F"5)0/7:0?Z5[K
MXDFB7PIJDC2H$:TD"L6&"64@8/N2 /K7FXQ/VD'_ %NCMP[]R7]=#P*BBBO2
M.(*]>^%Z,OA><LI :[<J3W&U!_,&O(:]S\$6TEIX.TZ.50K,ADX.<AF+*?R(
MKBQKM3MYG5A5[]SEOBS_ ,PC_MM_[)7FM>E?%G_F$?\ ;;_V2O-:TPO\%$8C
M^(PHHHKI,#Z3HHHKYH]LYKQ__P B3J/_ &S_ /1BUXC7MWC_ /Y$G4?^V?\
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M/_0#7JU>+C/XK^1Z>&_AA1117(= 4444 %%%% !1110 4444 %%%% !1110
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M/7&W.<=LXKT,/6CR\K8'!45K_P#"*>(_^@!JO_@')_A1_P (IXC_ .@!JO\
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M ;4/_ 5_\*];!22IN[ZGGXE-ST,VBM+_ (1W6_\ H#:A_P" K_X4?\([K?\
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MCNM_] ;4/_ 5_P#"C_A'=;_Z VH?^ K_ .%>ISQ[G#RR[&AX%_Y'33O]Y_\
MT!J]QKQSP9HNJVOBVPFN-,O88E9MSR0,JCY&ZDBO8Z\G&M.:MV._#)J#N>*_
M$.WD@\974CKM6=(Y(SD<KM"Y_-37+5[WXC\.6GB33_L]QE)4RT,RC+1G^H/&
M1WQ]#7D^H^!?$&G,Q-B;F,$ 26Q\S=D=E^][<BNO#8B$H*+=FCGK49*3:V.<
MHK2_X1W6_P#H#:A_X"O_ (4?\([K?_0&U#_P%?\ PKKYX]S#EEV-KP!>71\6
MV%M]IF\@B3]UYAV_ZMNW2M[XHZ-*S6VL1*S1JGD38'"<DJ?Q)(S]/6LCP/HV
MJ6GB^QGN=-O(8E\S=)) RJ,QL.217KTD:31/%*BO&ZE61AD,#U!'<5YM>JJ=
M92CV.VE#GI.+/FZBO0]?^&<Z2/<:(ZRQ$D_9I&PR\CA6/!'7KC@=2:X>_P!+
MO],DV7UG/;DD@&1" V.N#T/U%=].M"HO=9R3IRANAEI?7=@[/9W4]N[#!:&0
MH2/3BH'=I'9W8LS')8G))]:2BM++<SN%%7+#2K_5)/+L;.:X(8*3&A(4GIN/
M0?4UZ#X9^&_D317NMM&Y7YA9K\RYXQO/0XY^4<=.2,BLJE:%->\S2%.4WHC5
M^'&C-IOA]KN9 LUZPD')SY8'R9'3NQ^C"NQHHKPZDW.3D^IZL(J,5%!17":A
MXE\8Z78R7EYH5G%;QXWOYP;&2 . Y/4BK>EZUXNOWLIGT2U6QG*,TJS#(C;!
MW ;L]#G&*T="25[K[T1[6-[:_<=A17%:=XYDG\93Z+=PPQ0B>2"*4'!+*2%S
MDXYQCCN179R2)#$\LKJD:*69V. H'4D^E1.G*#2?4N,U+5#J*XSPGXUN/$FN
M7%H]K%# D32H026P&4 'MT:NSI3IR@^601FI*Z"BBBH*"BBB@ HHHH ****
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MTJ*:;6S$TGN4[72=-LI?-M-/M(),8WQ0JIQ]0*N444-M[@E;8****0PHHHH
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M31S+N')+L6**K_;[;_GI_P".FD^WVO\ SU_\=/\ A2YEW#DEV+-%5?[1M?\
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MD^C_ //Y_P"0G_PH]I#N'L:G\K^XUZ*Q_P#A*-&_Y_/_ "$_^%'_  E.B_\
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M_P")H]I#N'U6O_(_N9U5%<K_ ,+(\)?]!;_R7E_^)H_X61X2_P"@M_Y+R_\
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M31_PEVA_\_W_ )"?_P")H]I#N'L*O\K^XVZ*Q?\ A+=#_P"?W_R$_P#A2_\
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MY_-,_P"_LG_Q%>U44?5X!_:V)[K[CQ7_ (5#X@_Y_-,_[^R?_$4?\*A\0?\
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M .(KVJBCZO /[6Q/=?<>*_\ "H?$'_/YIG_?V3_XBC_A4/B#_G\TS_O[)_\
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M?#S5O^?BR_[[?_XFG#X?:L/^7BR_[[?_ .)KTFBG]6IB_M"OY?<>;_\ "O\
M5?\ GXLO^^V_^)IP\ :J/^7BS_[[;_XFO1J*/JU,/[0K^7W'G0\!:J/^7BS_
M .^V_P#B:</ >J?\][/_ +[;_P")KT.BCZM3%]?K>7W'GO\ P@FJ?\][/_OM
MO_B:</ VI_\ />T_[[;_ .)KT"BCZM3#Z_6\ON.!_P"$(U/_ )[VG_?;?_$T
MX>"=2_Y[VG_?;?\ Q-=Y11]7IB^O5O+[CA!X*U+_ )[VO_?;?_$TX>#-1'_+
M:U_[Z;_XFNYHH^KP#Z]6\ON.('@[41_RVM?^^F_^)I?^$/U#_GM:_P#?3?\
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M\"X_\:X3XR_\>^C_ ._+_)*J^$OAQI&O>&+/4[JYODGFW[EB= HP[*, J3T
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MJ&FFZ2ZLZ(2ISC'&RW2=_7^OS/8?"^C+H'ARST[@R1INE.0<R'EN<#(R<#V
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MT_5'F?A[X2Q6MPEQKES'<[<XMH<A">Q+'!/TP/J1Q7I2(D4:QQJJ(H"JJC
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2BBB@ HHHH **** "BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Jul. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jul. 31,  2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-36792<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">CYTOSORBENTS CORPORATION<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001175151<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">98-0373793<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">305
        College Road East<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Princeton<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NJ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">08540<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">732<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">329-8885<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.001 par value<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CTSO<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="tm2522255d1_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cytosorbents.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>ctso-20250731.xsd</File>
    <File>ctso-20250731_lab.xml</File>
    <File>ctso-20250731_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="tm2522255d1_8k.htm">tm2522255d1_8k.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "tm2522255d1_8k.htm": {
   "nsprefix": "ctso",
   "nsuri": "http://cytosorbents.com/20250731",
   "dts": {
    "schema": {
     "local": [
      "ctso-20250731.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "ctso-20250731_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "ctso-20250731_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "tm2522255d1_8k.htm"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 59,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 22
   },
   "report": {
    "R1": {
     "role": "http://cytosorbents.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2025-07-31",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm2522255d1_8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-07-31",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm2522255d1_8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CountryRegion",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Extension",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12gTitle",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001104659-25-072805-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001104659-25-072805-xbrl.zip
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M.4[_G3QWGHC;Q5[PL!JV0M)2AH>*S5X?,&4,$D$^3JPK7.4-#>NK9%JYNU>
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M(JK#5^QY4S#9'O*V&0 L#\_(A(0.N6+IG9<081+?SHWMU65]'U&HA&:)<G5
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MZSI#S-30@0X2?YZ-]3.6RNR V8!86.X@I$F @+M-&*5RG&7"6(E=UD(&BQL
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M(*V2TN)\O$[+;-)OE/DHM#+/2.LE$A,'YR*:IEFN^"Q9PHA**'H@R1T+]G5
M6ML4S+!SL]TU'&*+I+%C[-*FS#XWG@?F KZ68X5 $N(G5] ;.^J"/L*TJZOA
M+:PYBL!Z6"@20ZTF!.2U_C>T32Q6C<2 @S)=CHO>383 ^&RSV! ]]'MK3VSV
MQYU9GP,-UN/_1[>K7EIHKB_4"3!U$X- I89>C+DVU?&$)<0+FNS,DU6WZQV'
M6_N'/X75S3F&GI*S"/(#5EO];#>!K%*K6!3DAXVQAI/VMZ^YLK96,,."R0;@
M$A?=@<%!8ID37G;35?64W5)_:/0&&%8(#K+++YW3[H-#6M(76!UE.0R-!+80
MR*T$I<$ GBF61; [9[175&14%6UEARD?/R]UD3/G@(K@F1^K4=[<4IIY"+B5
MRG)H0EE>C<8=T3BA*H.?D ))EB>O:[W??0)J)/5A>2EB8H=:0<H.%"H;)UY7
MK3G2G,IV5L%,O,Q93Z0IAQKJ6@)UJ LFG9)-$U169C!C+ !\FH0.1(1F0W1L
M@C02S1:L7E@2J>TD+< PYOCC&,H,5'G>0%#]L/;8QKPMALDE6Y1]&&T:7/CP
MD)\>XF=M.9<D10IYDU6U<%R>I\(*!\=Q!?2YP$S)8P%>FAFO'[+M,5,V06"5
MV-?W0V-H^_Q(@=IE*^4L6"EG?L.,),M+IT8G73&M#]DZO5\*U)P3D_2HH74%
M2:8N5.\"H^%K,-39MV;(]EM@Q@6$9</BDHT0QJV#"LJ! 7&]S6IG02;.H?5^
MO],'+H\KK+S!.2!=75X4#1/X65^QO'5D0(ELA9*_O'18DO^E",X7+"EWI+5-
M\F2: O\'[,\&I3F3DNFK*5" '\YIMC9)UR*/W8#X%WDA8@M#I\3:@G])=)J"
M%I<VC,0.TXEYIXG".VR$SE2TF:+'YI*)+1L^MRMYL4[UB @RS1,#?2OX UG)
MM(.J9,5TH5$JIW%)NA+.A@<R319JLU\K-[TGQ/LJOR+['*R?H%.8LN%:TN0.
MD:,3H 97'N987F)P"C\O+,X-AYQ'0):<7"SDJX4<\"X&\3F.K\B76!L6SHS%
MJNZ(W.B25"#UL788>I8>$=YZ"[98Z&"!,*"C(X.[P "R L%"4G:AZ\2,GVQ7
M%V/2[]L&-V0/R*UD+;O>/F3%BS_YD,]W=H\.U-[!T=')SO[^X9OOOWO0?\!_
MGYWL[(6_?S[</W_UW0/(K6\>O.^R?B]L>'X:1@9VL!,AK!U?I"#RUOE^>,-'
M"]?ZO=4G_.65\_WMZY^O?LL?4ABAN6J<.^R Z0MU-DT'>0*8I#:.\W+31QSF
M1ULL@VX<]7>BX7MB=+9-O0&9KS UV=+UW$>Q:>G7)%X@K=Y[VC;?7&"7UFQN
MIN:1]L#VE2A"$HQH 6GE_)3^(23ZBD]_#3Z=BF0,1CZ'K.;$5(BDB3O#P$[W
MG@XM^N',1R(22Y/O@4(]A#0%^*:.V^C*@15;%)41L6>^8L-G@PVB 36(UZ9I
M!6X2F21A5:JPWL:JC[W-8R T102/H2J6XZD_:7;%.]/B5.1,(CF6?$6#SPT-
M*$AB@L\,QPK+O"2U)B.E@S24EJO/+PI*5GVXQ!]J@[)IW#>&H_?R=U,8GXQI
M,N8PR:\(SYI.PJ^(\9D@QJ&/(:86)EHM,V;)%I)'4*3D ^7C7%X2NP1#O/>D
M$KB<(8N*#<5_H'20PNVY2VWN%!)1(_R[L'%FIBWV]-Z+J!$[X8@U&*2-<VCU
M8><-ISIY=">&W;K*V>*"W$? =G:!!U?55XS^3##ZQ.4E";RF$2W8!*1+<_(8
M,C,D7C1<7J*P[W3NY4?MJ/#C@!*0=>^]K &0B+!-F&4JZ)]5J2'_!FS9><>%
M][;(PB21B$4JF;(4P)#(5!:3YIZ0:B?RG)R&GEDW]Z2N0,"W:.I*_G=[5FX+
MSZYC6=N65+<'#];^7G&"WT]Y_D/ _<I8_CK#:A8-EEP1SG/R4E2>#'1"-%R+
MJ9S2R-HLA9Q04)DH42+^*CD^DP,.NE!2412XRJ+:MF5= 2H(7B??7FJBL>;@
MS/*2#V<%$1%\);-7P(&STB8S0[GM>\>;Z<!I&&1!<:;W'AWLO3Y^_!4S/@O,
MD!!^M[#_-@(\4C(,':LX/BC.X5W"70V3*.(<+JBG$3GY16?U/ONPVFL+:0Z^
MM;L-Y7IE=_O"L$:<:IN5>B;80ZAR%@:9XTF=^BND\TR,H[4P8X()Z+F3Q!.@
M.J0VX]1D5D!24VJ %[]=Z:(TQ5?GWF>.B%XHL?GDO7L2EA"V!/V6/XFG16!H
M@5/=CH.L<5("7Y[" B1M5!#\=H3XH@-1YY1P-9?>6D>"*+U1O&4!L$,BMSJ=
MJ9& .\HY7-_(BA?HU7D3GSRFL[C>YHNF5DFFNI%8ZX]WMU<?RZ[O0H:[V[MD
M _BZC(@3!*-I)-48H!<)S22F[>Z>C7^_..(=8;SV^*[ O=GKN-A)^#<'[/J=
M 7OB/1F$M\Y,M&5?U")7QM\<I!MW!ND.A[Z2Z0TJ5=,,:-<($'</3NV_-:R?
M_ 'T%>TY=UYY7IRV=PL\OVA%X^CF I&KW%T44DG%%2%508:$KP9I5H%(OK;4
MSG!!NHIS<-K@M.9$1*JEJ(O,&A5T=7V<KTXZY>_[!.R.DC_/R3 8A;_V<\JG
M\4486!#H0$O=D(HT!L4&[TDZDN02GF"_' K?"UF8IZ8 DA9<44.&V &=B80@
M#NL"TOH<WQ;F?N44WFXM- N$_K/.7%U>DMH_LB.\VBP%"._MH6DFU-Y<L*1P
MAC;SN;*6"DPY4:5.J.6JJO!N<-@$\X8.3&*?C0HRKA.M,PCWCG\ZW.^N/@?)
M9+%);42Y:U2",B-C##AR('&L[&WOK/?^.\967N[O+"\=I(9R>J,IH9;:J<IQ
M[NR_A;H;BV[4]4*449B@L5A?<\L9FU0<8YUD^M19TH<2<WCOQ4)P=0,;65Z2
MG#KQ;V.^D2U*Q\E&#)'KZ\).9HE_("MR@75F&7,A(O)K7CGB.WNAM&Q/U_'J
MFVW;.^[@T5I_;?WQ+/I].]K+J5-H=*Q).Q@ZC@M.%T$W) M2WB"?P+.GW\P;
MAAWU2D]U-M)UD9W15'A+47A//<\VOOD@9'K>[\::RD I'UXGG0;N2)3)Y5(Q
M]2&3?+OVC:_WY<&X:,O7-%(BO2V:*%N T7#6<49INGE53HP;YBX-1,UG_]ZK
M(5PC)ZUL%Y(UB\94"56'>:F^AXS\=UPZA!50F0'+WA8U4XT"">->C6GWGZOO
M$')J*L'X@%B_,S"AV9_"#0.H:):9P.JS)^UBDIH/."ZOQ4G,CA\R8Y>T;>]P
M-3H-W. 'SPTP8D,,4VW):]_1X&.RAB>/ZZ#.[:!K-$[PT=L/H:<%K1=J[.0>
M#$TJ?O1P9#;7J:M#Z6Q,S1ZDFDZM>>5P'>)L6CP.2?L?LK XQQ&9N&8G8%2:
MO<:-Y3RC(KI!81S5$%P6/;7^[!O*,\+I #B/?<F/+TZ.<N=,XD7SP)17!H18
M"VY0KQG:AM>=_6T>)N54BG08PZ"8)47.P^5<IVQBWWV H_"L0.A,LEYO0$35
MPEP9MHV29]$8(N[?'66PI*2G"$-6'P?,?&^X>I26EA8+A%PH(Q!(-: OD*1>
M)-C599Y4J>3U^1P"8<.-9B423Z#,@FK6C*(!UZ*A2[ N1[DN67G/6. =*AW7
M_U[)"E_V@;ZL'),UE?AD(_Q:Q\T,M8VA6#S%P3H?1J1<4 4=UY2ZJT&M4]+K
M0#[/-C;F-.TF;VDD$IV5!KPHF=/TQ,C8&VL0WD/# <1-%GU@*J]RJM8D,M<-
M(1DTP[K!RH?R'8Y<!(X;A*AJ23_._]><[;FQT=#@/8M97N*-MY3YNIZ4ZN9)
M/)-GN"K4VO,GH>R^K0%83I"Z]C6=Y-2DJ&;TJB5I"^I@4]0LJZ%:AA0-J4<#
MJ,;X7CS- )JH7:R*V7^KK),W.SZ8YAFL[%MJ/>=7/6\$?JW<^03AG<\I&NM#
M'%Q! 8SJC@-]-G)"&WK0\>GR4K_W=$/]3[^W$72Q?N_YL_^%D?M=O]=??]I1
MV7<;3]?N9=['%WO"KS0E::FU;X/ZW"?]>>$A+R_AE+&5C:=TR/4W^KUGWX9#
M[J_3(:\]Z=]TR%^T['UM='9%;9XZY )A?VGM-?M04;OZI#^3$":KX[*^1I.L
M )=YIW2'\EYJU7WO^.SU\9EZ!,Y\+&V82$Z])AWW>#CO+_-3G#V>:Y 7'%A<
M*_720/EVUULAM47S-=?50F-UL8@-TN3)M]R"I-XX.9I:):=S^KP7<W&CAT(M
MM,3Q9PNHD5REZHTPMK58S-TB+AO):;Y,N4ZC[BPOM?(>16925CWE%25X*R%;
MCA17B5H,R2$XUSGPGD0/CB^I^BGI^$Z&@0CJ([K6HQ"&ZBR;BW'X$D9N*)CW
MC7'&.7?CRY-\-+W>Z*PPI6]>V*R7GI!KG/(98E=)UGF,!Y'Q9S\KI/8]-<A-
M*8H-AKTB[08:;4DTXJWN>W)"=9,^[)#<^V01^SC86=,+  606OA1]JX)\3/N
MV08P:M8S?3*_;PIR6W?-GEK0:84Z+FH7C3NSUI@RIYKDT$*96"D[CUT7C=Z?
M$]\9,V!21XU ?,UN51- @^T<\1@5C'BD0-_83'"^[QH7R=<=W=C= )"-I,-=
M3_W,732H"0O0O8L)M=0V7*MRG[EN:MNKVPBKW!S.";WU0G1&/,G<MA#G ?0=
MY)<L9*!Y\(JI34*I.R$;&\QG6"7T=8KB<^6T-<U :^B?QSE=W _4<(ESW>FP
M[G]!\H6#U/610DQDTHRP$3R:$>3R$E&AI4HJ\J_5<5QU4QC78Y</XP9?3 CE
M$N9>ZRDHL1I:5C!N"QM=< /.("EL1AT2C IJ*22*X:8[(/R*)X4T4JDM"N_Y
MH=ASZ."G?4YA\1!8D-C)9IF/#$'D?C7BJ_MRQK#CK<_SREUHQS&$; <O)#AE
MU&.VW4P3W)B[RI&'M67Y,?ACDUPR*P X1VP7.S^+DN8J!775M&PX<J3^ QRQ
M;[=I_JV5MT$1[2TO-52Q*UT"38D \Z)9R1MY;*!/G/_D6@?&JW$>UHV'UOE6
M,F/)9 ^LQOLZFAF/>!L(.->6M-&WK6Z4LH"N2.$ T#U?_BGGAK([LZ5Q[QZ/
MB1AVE'+BPJ< XTEB*&GZ5YP4B)AK7VEE?[#!MV\8_$@ 68C[(#6/@Y9W9:0K
M+S6.)71LM]*M73LW0[,-??$[Y6DMN";$-:7/<D,(T-$2"@QGSF#*@-5EF5 =
MOZ5PG&_:Z_*,<XEQ/O=$#[B+WW?CJ]_W"SK0W>V= 37R;+'A1O_XN<;QGSXW
M9Y.,P]R]4/_8>+J!__ZZJ.Y=6]'\7NM];IWTIW3;Q[N..@(N:DW6:QVQMZ24
MM#\&@W7315VI2Q.-,[*@+/<9EB  =VJ"2L4F,I0KDI9LJTWG&H]A&=)Y+/1#
MT7/IHM?J=UF:RCIFH@X*,G%5:9%("CO5@%%I8%EGB%2.>Q-B,H#?[[8.Y5+5
M ;L]0F-NJN?AA=&:!D;T3!]0]9[S (MT@GTGU+NEOE*@]E@^,KU13P'^',?H
M!.V8 . ,>2R<F8"CL3L@*,8P19S:.ST]G^\FM[BB#2]+0@_M$OJ'*[M<9Y?"
M""6Q4LM"62_71TXXG,! #JT)Z,BJLJ#F15SC#(N#.X$QLK!H;@:^I3'P_-&(
M.X>.+>Z$.P$R:I)S,7,GT<"+\>P:(C',Z<* Y:6L8H%/,5>J(VEEFO44M2-D
MA$Q(\R^ON(.[Q%3;.6DTZNICG]V-=8K+*)2"VRPC=0V&0C!!Q:/"%)138IB.
MV#T4*"FOZQ?9RB@N1'VX%&@;(_WO:*"U:Y,N:%4L()-2(W^=09XMTN)FS3I#
MU^)42TIUN^M=*^E7*O5]")[;[4JTA^1@#+P6C89NB5BD-K)%7[2;^?FL*Z#)
MH'*A>5Z'>M]7*2Q&QL+P4*JE_%(ZL]9;SH@>6$QAL4*QZOAE9A';8"4Q1N ;
M;"6Q5ELP;!5G"5!T%%4IXS-C#A<*7JO4(IJIEQ+NKFB,FTYS:IUH?7D6GZ<;
MZT&<XQ.)2-;\BOG/E2U,?19,V.+W:23_X848;V&O1:>%+WP4@<T0P8,9@#*)
M6]:+<V)@#LT5K%Q*L !$9UU'9_T@[XD*N8@[,'1]F_!.^T(7ZBI9_%X[37;4
MD:.9.T1*<0&A1:MA9J.7]:+VF^+H*X0Q>3P38477=P#G>K.+)]ACG3N+S;(+
M/-'<@ORFY7&G6;5WP-W$ ZJS13BC%19=?#W)3AQNEZB_ CB2^"<N=P5\65X*
M:;)$L>0)=14A-/?9K-$[X+QMY (U-(O@A?$$).CKDX2$QBD?TWB)[?N34^T!
M!H)I#A5-\KB=O83Y^TX/='O*%E^M%10<8P2VBJ%G<H)[ 7/FD82PL:^7^SOJ
MMN1=#V> ER/G9R6W!N8>Y(4PA[A*RCMF]4*>&''%X?N $$Z&\B@7)OO.;'7)
M;IR:LD9.ENT1<-G-,$%6J&2!]X2"[V($/OEJ!'XY!RI"3.:BU%_Y#<0MO^SI
M3,>ZX_]HLF]^8J%@QQ2ORB?!K;KOJA%S<+HJQVQV=\Y/V0]+&F<ZX,MR JLH
MID5ITHXTC+JDRPA&/ASI.?+,Y"#7^6\5I920EA.:&]>:Y93Z 34<_&T-CB6]
MOUV'_&]4X,\,OE;F.+\%@KG+PCLPK+CBQ.Z&&LFE#=A@N-! '9;,P0+SPC*N
M<OF(V!C7R@95>U^VM&\H:BAZZPL_"D5,F+^VU!7Y<,9SZZ.I$S&O?V=VF-+%
MD/@27YZ&87(]@F CUO=H_WAG[S&8EQ7>/<?+_=E22UYAY9,J@<;*=N)T HU4
M>F7:,JC4OGOZ'-]O\'L9<7GIT(\]<_6M]=<V6K>5R0LP/E);<FMA0$R]R2]S
M=4H<!G)3#(YYE 6\Y1<GKW$C:;K!0^).31$"'<X#+B K8RG?Z#;#O??!H;V=
MW>];]1G<?:*-_1Q>G)UJAZYCL9#'T"O\"4<1@4=$;MT3^9+;<%G0NO5 /([*
M/( PX..Q_VP'EGVBUIZ('U4 3!C)K>($J/(B0W;?9)94VR,#D'L\H\F;X(&"
M2NW<P#3X CX.O#$Y&!AHY-*N[^]+*?XR,/455'&(93/$YP[3Z\=!J0$F2A#&
M'T(X-X'&_)GSQ7".[F/S)QO <-ZX_6Y@$FLNI?LF*0@EM:3VT[;OE/(IX^2D
M9TVI*B@G+G0="@X67RKH4BF,,M2[@%&]X(PV.LHA\#^QHIB8; 1AP7X UCCH
M% K &^ 5OU QMA/Q>%2.M3W.>" >)'% "AF4@82.@;P_4#/2M6?S1SO37AA?
M22>M^-86SMSV2V5'@B_0FO&<^3)'3T(> 2=T8V A53J,@(]TG.+P.8>0:Q1D
M[,=>V5U;57LO3R&A>L^>]%I'T8HA^G/Q132+\8DL-1!20)J&S5\;5K/#6WA4
M4DDWOP-_7OZX\ Y!.2HEG#\(]U:4C1BQ1!UWJA$AMP!>;#A=\FT!XO,9^5N"
M2"I&MFBLDYPVQELQ]/4;;\3Y,I6(FIG<P-5GZKTE3^E[.UQ?[Y_MG'CBIT2Z
MVELIKL @- AI7GMV[N7N$?ZANZT>O=X_>MS$)%(=9,17'.13HO.$B%;-6)70
MW=- =ZVW9XSU#3%YCB.=FF%5U%+Y&I$M7A\34UC:1^*Y3;))]72.WZJ%[%9D
MY'4&JW;DRD7:50L"];XH*QC&UX#-*,Z*B8V/)]1L<N:#\Y=CBGU+_+$U:$>$
M07V1:4)1.)#HD"]&5$>D>JK5NBR[P;9.VU.'T&=]/V,;^F QK"YQX8O:A<ZB
MJ_J1CVKSK7*>,=Q2(NXY3#T1UVZ"/]\3 ["E,8U]G=^ BH[:HOHZZH2@[+P0
M)Z<X'_8]@5!3X#& ?,M2KXV:VMM5B+93_R72TYM3K#"(^5--6)&T]?6\MP5K
MV,U2BBR#[.*2;N%-"VR\=@XHI>&4M;]:TC?Y8E6VY+@&5"BW;CXA[[==\=Z?
MTBP&/]@[/NNN]_M[OXA;3_UDRE-3_.C_.L%&7EK_1[#ANO\Z\A8D>, KV#?[
M9HB1NZ>[>^&Y:CS>_7ZG?OS/_Y)"@_K!G$F*2>@%791B+-;1I@*$&O);6FDM
M$_9E+R]!B;#E0JJ_,@/J"J]TZ9'L[?:X+"?%BY45ZWKDZ2N\X=P#8:Q0RH2\
M6-. 3YWAVUCJ,5[JR SR_&+V?FV9X]-_T>,_19%H!&;[ZR\WUOX<6KH^ZUW<
M3T^_NI^^U .7[@VYN](N[A[E.6?7L?^4HR!_1G.0Q9W@_HR\ PJGCCACJ^MA
M#^ND-+[-'M=:D84C8;40N"-1R]!*/+2*&EJ2.!"+3?-;A;F'T]KBHSN-(9W<
M@#@/!=X3&]*JH4'I1LTNO7WB^"8,;"VJR*U.<?4C&]QUI.B"5ZJ=B+7"U>?/
MQ>PKS.VKXQUTU*"2JPU)D:C3=_-.\UW-:2ID'[,&V%'YX%>Q^BA(.:PX&4 N
MKO)M\*N2IIREGPVJ@F+F!44VFE>WA]N9"53^[N:@$OLDXY#W.3/NQ,X0G=6K
MLA27H?7CI"AQEA1+ZGCO([_3B0]$T#:]1F\%NCZIG^Y4G(5EO#H+5;T3]%;_
MJ!CG51+//XV:#\$N_&.Q:>=?)@C./V/WH"5I/O^)-]+G'X>+8Z\-+@42U]<R
MR4MI^WA][>(2"(^EK *VH'84M:-[,<D>8&N>$_1N02D"+S;M#:"ZD0W?D_=+
M7BF!'IM)5]IYSX/WYMR,IJ)Z\:AU5+M&(E*PO'NGU@5 (S0MR#SF/,O:J11Y
MG./ NN SD*1BSP&7/704M_GRS?>EJX?F7MB\<-F1(L [N1#8UPKE$OBZ?2M0
M;KC92O!Z\)B4;< XZ.:NV6-<#"",S!WH58BD*!V467$+>\KQ]^G %"9KE5I1
M2'TKV5HC3JWYWM ^*2^%8=+LUBM7H]_L'@K>KYA=F'0=<^GKC.B3MHU^W33'
M>ROLX^*L]V'%1,K.+#$\R:D<CI7&7&SQ!E]/(^? %A=%L&U]4!H[V^'+V3$[
MW^<*SOF2^.9JO_O/#INTLS0E=7:P1R^\IH*'Y:7UU>!U 'NH)K%NN*9DKKK?
MC9_JQTK3C:S8C\Q6-*?[T:?]"_A:J%TT\XQSNOBHUNS+G"JH</3C/.'\9^_S
M8#;F41$B4*XDP4]!,XT#22?LM=?QI2U\X1D0A2PAROLWQ2RAG[;"T>86JI+3
M0K.CK\7,0=8_4S*8W%0Z!8433F(B3KTB>ZKB1!3+-,1F%)E#C-JWT<G/1FRQ
M4E\0FD/:)$'4T>#<. N E7-0% PGHY\CZ--;!N9\+;F4D;("A>9IZQD[]9MI
M]"+1A!E0NL\L&Z7CSX8O!=5%J+V.9<4>:TW,5TH5M;A6B;XJ[E<;BC^ON=W;
M;9_3OH=SOR 4>"FVVELA*F^CB37_+\F&_U(5U0^K_)4^96(:4SHLE*RH?-&H
M]R5P[IY2N3.>G1ABU3_TB,F!1"WL\K$U0U@Y&0B6N/GQ$,S>N(^XN_7^$RPP
M20P,J%-*.#S01?D1QX>F#%Y3$A&_^4'UOWVRT?^89_-V>Y(*L/Y[WJ<@>/?Q
MIOI4Z+6[?<BQ?O;1AL9%;53YF)/MT,7*)]2H#.CU<D<]U.ED4^W$.LNT^KZG
M=A+SCIH2NHXZ&>]_@LWNG7JM@;.W/_8$;[>M^]2H\)$Y[=V\.,\VU;$4;KY0
M1Z#1O\JI\\G<+M?@NK)[O/\+L\97YZ^/MO\?4$L! A0#%     @ Q)7_6AQ
MDO8K P  [@L  !$              ( !     &-T<V\M,C R-3 W,S$N>'-D
M4$L! A0#%     @ Q)7_6O#TV5;]"@  ?X8  !4              ( !6@,
M &-T<V\M,C R-3 W,S%?;&%B+GAM;%!+ 0(4 Q0    ( ,25_UHY?M4>60<
M -Q7   5              "  8H.  !C='-O+3(P,C4P-S,Q7W!R92YX;6Q0
M2P$"% ,4    " #$E?]:%+;;<7<2  !G8   $@              @ $6%@
M=&TR-3(R,C4U9#%?.&LN:'1M4$L! A0#%     @ Q)7_6G'34C? (@  6I8
M !8              ( !O2@  '1M,C4R,C(U-60Q7V5X.3DM,2YH=&U02P4&
2      4 !0!) 0  L4L

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>tm2522255d1_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="ctso-20250731.xsd" xlink:type="simple"/>
    <context id="AsOf2025-07-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001175151</identifier>
        </entity>
        <period>
            <startDate>2025-07-31</startDate>
            <endDate>2025-07-31</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2025-07-31" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2025-07-31" id="Fact000004">0001175151</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2025-07-31" id="Fact000009">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2025-07-31" id="Fact000010">2025-07-31</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2025-07-31" id="Fact000011">CYTOSORBENTS CORPORATION</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2025-07-31" id="Fact000012">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2025-07-31" id="Fact000013">001-36792</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2025-07-31" id="Fact000014">98-0373793</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2025-07-31" id="Fact000015">305         College Road East</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="AsOf2025-07-31" id="Fact000016">Princeton</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2025-07-31" id="Fact000017">NJ</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2025-07-31" id="Fact000018">08540</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2025-07-31" id="Fact000019">732</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2025-07-31" id="Fact000020">329-8885</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2025-07-31" id="Fact000021">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2025-07-31" id="Fact000022">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2025-07-31" id="Fact000023">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2025-07-31" id="Fact000024">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="AsOf2025-07-31" id="Fact000025">Common Stock, $0.001 par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="AsOf2025-07-31" id="Fact000026">CTSO</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="AsOf2025-07-31" id="Fact000027">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2025-07-31" id="Fact000028">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
